Two parallel signaling pathways couple 5HT(1A) receptors to N- and L-type calcium channels in C-like rat dorsal root ganglion cells

被引:43
作者
Cardenas, CG
Delmar, LP
Scroggs, RS
机构
[1] Department of Anatomy, College of Medicine, University of Tennessee, Memphis
关键词
D O I
10.1152/jn.1997.77.6.3284
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The coupling of serotonin receptors to Ca2+ channels was studied in a subpopulation of acutely isolated rat dorsal root ganglion (DRG) cell bodies (type 1 DRG cells), which have membrane properties similar to C-type nociceptive sensory neurons. In these cells, serotonin (5HT) inhibited high-threshold Ca2+ channel current and decreased action potential duration. The inhibitory effects of 5HT and the 5HT(1A) agonist 8-OH-DPAT were shown to be antagonized by the 5HT(1A) antagonists spiperone and pindolol, respectively, indicating involvement of a 5HT(1A) receptor. Several observations suggest that 5HT(1A) receptors couple to N- and L-type Ca2+ channels by two different signaling pathways in type 1 DRG cells. The inhibition of Ca2+ channel currents produced by 10 mu M 5HT occurred in two phases, an initial slowing of current activation rate (kinetic slowing), which was complete within 10 a, and a simultaneous reduction in steady state current amplitude (steady state inhibition), which peaked in similar to-1 min. The kinetic slowing, but not steady state inhibition, was reversed by a positive prepulse to +70 mV (prepulse). Blockade of N-type Ca2+ channels selectively reduced the kinetic slowing and its reversal by prepulses. Chelation of intracellular Ca2+ or blockade of L-type Ca2+ channels selectively reduced the steady state inhibition. Recordings using the cell-attached patch configuration suggest that steady state inhibition required a component that was diffusible in the cytosol, while kinetic slowing occurred via a membrane delimited pathway. The application of 5HT to the fell body outside the patch pipette reduced macroscopic Ca2+ channel currents in 33% of small-diameter DRG cells tested, indicating the participation of a cytosolic diffusible component. Application of 5HT (a membrane impermeant compound) outside the patch pipette produced steady state inhibition only, whereas similar application of membrane permeant 5HT(1A) agonists, 8-OH-DPAT or 5-methoxy-N,N-dimethyl-tryptamine, produced kinetic slowing and steady state inhibition. Together these data sun est that 5HT(1A), receptors couple negatively to Ca2+ channels via two pathways: a membrane-delimited pathway that couples to N-channels and actuates voltage-sensitive kinetic slowing and a pathway dependent on a cytosolic diffusible component and free intracellular Ca2+, which couples to L channels and actuates steady state inhibition.
引用
收藏
页码:3284 / 3296
页数:13
相关论文
共 48 条
[1]   PHARMACOLOGY OF CALCIUM CHANNELS IN CARDIAC-MUSCLE, VASCULAR MUSCLE, AND NEURONS [J].
BEAN, BP .
AMERICAN JOURNAL OF HYPERTENSION, 1991, 4 (07) :S406-S411
[3]   INTRACELLULAR CA2+ BUFFERS DISRUPT MUSCARINIC SUPPRESSION OF CA2+ CURRENT AND M-CURRENT IN RAT SYMPATHETIC NEURONS [J].
BEECH, DJ ;
BERNHEIM, L ;
MATHIE, A ;
HILLE, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (02) :652-656
[4]   A DIFFUSIBLE 2ND MESSENGER MEDIATES ONE OF THE PATHWAYS COUPLING RECEPTORS TO CALCIUM CHANNELS IN RAT SYMPATHETIC NEURONS [J].
BERNHEIM, L ;
BEECH, DJ ;
HILLE, B .
NEURON, 1991, 6 (06) :859-867
[5]   MOLECULAR-BIOLOGY OF 5-HT RECEPTORS [J].
BOESS, FG ;
MARTIN, IL .
NEUROPHARMACOLOGY, 1994, 33 (3-4) :275-317
[6]  
BOLAND LM, 1991, J NEUROSCI, V11, P1140
[7]  
BOLAND LM, 1994, J NEUROSCI, V14, P5011
[8]   MEMBRANE-DELIMITED CELL SIGNALING COMPLEXES - DIRECT ION CHANNEL REGULATION BY G-PROTEINS [J].
BROWN, AM .
JOURNAL OF MEMBRANE BIOLOGY, 1993, 131 (02) :93-104
[9]   VARIATION IN SEROTONERGIC INHIBITION OF CALCIUM-CHANNEL CURRENTS IN 4 TYPES OF RAT SENSORY NEURONS DIFFERENTIATED BY MEMBRANE-PROPERTIES [J].
CARDENAS, CG ;
DELMAR, LP ;
SCROGGS, RS .
JOURNAL OF NEUROPHYSIOLOGY, 1995, 74 (05) :1870-1879
[10]  
CORNFIELD LJ, 1991, MOL PHARMACOL, V39, P780